precision medicine

Biomarker-Guided Therapy Leads to Improved Response in Phase 1 Trials

06/05/2016

JCP Editors

Using biomarkers to guide treatment in clinical trials may yield higher response rates than similar drugs not guided by biomarkers, according to an abstract presented at the American Society of Clinical Oncology...

...

06/05/2016

Journal of Clinical Pathways

Research in Review

Integrative Genomic Approach to Cancer Care Leads to More Actionable Variants

06/02/2016

JCP Editors

A genomic approach developed and tested by scientists at the Icahn School of Medicine at Mount Sinai (New York City, NY) helped support decision-making and led to therapeutic recommendations for a group of patients...

A...

06/02/2016

Journal of Clinical Pathways

Research in Review

Report Outlines the Path to Improving Biomarker Tests for Targeted Therapies

03/21/2016

JCP Editors

Biomarker tests are not being adequately used in clinical practice due to a lack of common evidentiary standards for regulatory, reimbursement, and clinical decisions regarding their use, according to a report by the...

...

03/21/2016

Journal of Clinical Pathways

Precision Medicine: Using Genetics to Drive Treatment Decisions

02/15/2016

JCP Editors

The emphasis on precision medicine continues as health care providers discover the value of using information about a patient’s particular disease to inform treatment approaches. Genetic testing and personalized...

The...

02/15/2016

Journal of Clinical Pathways

Research in Review

Determining the Value of Companion Diagnostic Tests

08/10/2015

JCP Editors

A recently published value assessment tool can help provide information about the overall value of companion diagnostic tests (CDTs) associated with targeted drug therapies. CDTs are essential for the effective use...

A...

08/10/2015

Journal of Clinical Pathways